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The precise pathophysiologic mechanisms that cause the adult respi- 
ratory distress syndrome are unknown. Indirect evidence from human 
studies and extrapolations from animal models have suggested that 
phagocytic neutrophils are important in the pathogenesis of this dis- 
ease. To further evaluate the role of neutrophils, the frequency of 
neutropenia in 18 bacteremic patients who had the adult respiratory 
distress syndrome was compared with that in a control group who had 
bacteremia alone. Three of 18 patients in the group with the adult 
respiratory distress syndrome were neutropenic as opposed to one of 
18 in the control group (p >0.6). Histologic examination of the lungs 
from two patients with the adult respiratory distress syndrome and 
neutropenia demonstrated the absence of neutrophils. It is likely that 
there are many pathways that lead to the adult respiratory distress 
syndrome. Although neutrophils may be involved in some of these 
processes, this study demonstrates that neutrophils are not required for 
the development of the syndrome. In the appropriate clinical setting, 
the diagnosis of the adult respiratory distress syndrome should not be 
excluded solely because of neutropenia. 
The label “adult respiratory distress syndrome” is frequently applied to 
acute noncardiogenic pulmonary edema [I]. Although the precise mech- 
anisms that lead to the adult respiratory distress syndrome are unknown, 
it has been suggested that phagocytic neutrophils are a direct cause of 
the pulmonary damage [2]. The evidence supporting an etiologic role for 
neutrophils in human adult respiratory distress syndrome is indirect. 
Increased numbers of neutrophils have been found in the pulmonary 
capillaries, interstitium, and alveolar spaces [3]. Bronchoalveolar lavage 
fluid from patients with the syndrome contains increased numbers of 
neutrophils and increased concentrations of neutrophil secretory prod- 
ucts [4,5]. In addition, the circulating neutrophils from patients with the 
adult respiratory distress syndrome possess characteristics suggesting 
that they have been activated in vivo [6]. Furthermore, stimulated neutro- 
phils are able to kill human cells maintained in tissue culture [7]. 
In many animal models of the adult respiratory distress syndrome, the 
lungs can be protected from injury if the animal is made neutropenic prior 
to administration of the damaging agent [8- 121. To determine if neutro- 
phil depletion also protects the human lung from injury, we examined the 
effects of neutropenia on patients at risk for the development of the adult 
respiratory distress syndrome due to bacteremia. 
PATlENTS AND METHODS 
A list of patients suspected of having the adult respiratory distress syn- 
drome was compiled by reviewing records maintained by the Respiratory 
Therapy Department for the period from January 1, 1981, through Decem- 
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Figure 1. Serial white blood cell 
counts in venous blood of Patient 1 dem 
onstrating leukopenia during his hospi- 
talization. 
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ber 31, 1982. Included in these records were all adults who 
required assisted mechanical ventilation in the intensive 
care units at University Hospital. Using computerized 
records from the microbiology laboratory, we were able to 
select those patients with respiratory failure who had two or 
more blood cultures that grew a known bacterial pathogen. 
After reviewing the available medical records, we identified 
18 patients who fulfilled our diagnostic criteria for the adult 
respiratory distress syndrome and were bacteremic within 
48 hours of the development of respiratory symptoms. A 
patient was considered to have the adult respiratory dis- 
tress syndrome if all of the following criteria were fulfilled: 
(1) acute respiratory failure requiring mechanical ventila- 
tion, (2) the ratio of partial pressures of oxygen in arterial 
blood to alveolar gas of 0.2 or less, (3) bilateral pulmonary 
infiltrates on chest roentgenography, (4) pulmonary capil- 
lary wedge pressure of 15 mm Hg or less (if available) or 
absence of clinical evidence of elevated left ventricular end 
diastolic pressure, and (5) static total respiratory system 
compliance of 50 ml/cm Hz0 or less. We hypothesized that 
if neutropenia protected the lung from injury, then the fre- 
quency of neutropenia in the group with the respiratory 
distress syndrome and bacteremia group should be less 
than the frequency of neutropenia in bacteremic patients 
who did not have the syndrome. To test this hypothesis, a 
control group was chosen by randomly selecting for each 
patient with the respiratory distress syndrome, a bacter- 
emit patient without respiratory distress who was of the 
same sex and within three years of the same age. For each 
patient in both groups, we recorded total leukocyte counts 
and the percent neutrophils that were present in the periph- 
eral blood at the time of onset of respiratory distress or 
bacteremia. 
RESULTS 
The mean (f SEM) number of neutrophils in peripheral 
blood for the patients with the respiratory distress syn- 
drome and bacteremia (13,800 f 3,800/mm3) did not 
differ (p >0.2, two-tailed paired t test [13]) from that for 
the control bacteremic group (9,300 f 1,600/mm3). 
Three of the patients with respiratory distress and bacter- 
emia had neutrophil counts below 1 ,000/mm3 (0, 12, and 
9 1 O/mm3), whereas only one patient in the control group 
was neutropenic (316/mm3). The frequency of neutro- 
penia in the group with the adult respiratory distress 
syndrome (17 percent) was not statistically different (p 
>0.6, two-tailed Fisher’s exact test [ 131) from the fre- 
quency of neutropenia in the control group (6 percent). By 
constructing 95 percent one-sided confidence intervals 
[ 141, we found that the minimal frequency of neutropenia 
consistent with the study results for patients with respira- 
tory distress was 5 percent, and the maximal frequency 
for control patients was 27 percent. Therefore, the possi- 
bility of a partial protective effect of neutropenia was not 
excluded. 
Because it has been reported that peripheral blood 
leukocyte counts in patients with the adult respiratory 
distress syndrome often decrease abruptly at the onset of 
lung injury [15], we examined the available serial leuko- 
cyte counts from one of the three patients with respiratory 
distress and neutropenia (Figure 1). The patient (Patient 1) 
was a 25year-old man with hepatocellular carcinoma 
who had received chemotherapy consisting of mitomycin- 
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Figure 2. Top, lung tissue from Patient 1 demonstrating 
diffuse alveolar injury with intra-alveolar exudate and hya- 
line membranes (hematoxylin and eosin stain; original mag- 
nification X 80, reduced by 50 percent). Bottom, detailed 
view of a representative area of lung tissue from Patient 1 
demonstrating mononuclear cells without detectable nef.+ 
trophils (hematoxylin and eosin stain; original magnification 
X 800, reduced by 50 percent). 
C, Adriamycin, and 5fluorouracil. Because of persistent 
vomiting, he was hospitalized and found to be neutro- 
penic. At the time of admission, he had no respiratory 
complaints. On the fifth hospital day, he experienced 
chills, fever, and hypotension. Culture of blood samples 
obtained at the time showed group D enterococci. Soon 
thereafter, he became dyspneic, and within 30 hours, he 
required intubation because of progressive respiratory 
failure. Chest roentgenography demonstrated diffuse, bi- 
lateral alveolar infiltrates. Measurement of arterial blood 
gases immediately after intubation revealed an oxygen 
tension of 93 mm Hg, carbon dioxide tension of 34 mm 
Hg, and a pH of 7.31, while the patient was breathing 100 
percent oxygen. His static total respiratory system com- 
pliance was 25 ml/cm H20. Despite intensive therapy, he 
died on the eighth hospital day. As demonstrated in Figure 
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1, the onset of neutropenia preceded by at least several 
days the first evidence of the adult respiratory distress 
syndrome. 
We considered the possibility that neutrophils may 
have been sequestered within the lungs of the three 
neutropenic patients with the adult respiratory distress 
syndrome, despite the greatly decreased numbers of neu- 
trophils within their peripheral blood. To investigate this 
possibility, we examined tissue specimens obtained from 
two of these patients who died and underwent postmor- 
tem examination. Patient 1 was just described. Patient 2 
was a renal transplant recipient with azathioprine-induced 
neutropenia in whom respiratory distress developed in 
association with Escherichia coli septicemia. Multiple 
areas of the lungs from each of the two patients were 
sampled for histologic study. In both patients, many of the 
alveolar septae were covered with membranes com- 
posed of fibrin and cellular debris (Figure 2). Interstitial 
Figure 3. Top, bone marrow from Patient 1 (hematoxylin 
and eosin stain: original magnification X 80, reduced by 50 
percent). Bottom, detailed view of a representative area of 
bone marrow from Patient 1 demonstrating the absence of 
maturing neutrophils (hematoxylin and eosin stain; original 
magnification X 800, reduced by 50 percent). 
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edema and regenerative pneumatocytes were present. 
Although occasional monocytes and lymphocytes were 
evident, no neutrophils were detected. Examination of 
bone marrow from both patients revealed the absence of 
maturing neutrophils (Figure 3). 
COMMENTS 
In 1967, the term “respiratory distress syndrome in 
adults” was first applied to the acute development of 
noncardiogenic pulmonary edema and respiratory failure 
in association with a variety of nonpulmonary diagnoses 
[l]. Since that initial description, a large number of dis- 
eases have been associated with the development of the 
adult respiratory distress syndrome. Grouping these con- 
ditions together into a single syndrome has proved valu- 
able, particularly because it emphasizes that the patients 
share distinctive physiologic abnormalities. Also, the rec- 
ognition that a patient fulfills the criteria for the adult 
respiratory distress syndrome has important therapeutic 
implications regarding ventilator and fluid management 
[161. 
Evidence from human and animal studies has suggest- 
ed that phagocytic neutrophils are involved in the patho- 
genesis of the respiratory distress syndrome [2]. In many 
animal models of the syndrome, neutrophil depletion pro- 
tects the lung from injury [a-12]. In our study, however, 
we found that neutropenia in humans does not totally 
prevent the development of the adult respiratory distress 
syndrome. Thus, for the neutropenic patients, other etio- 
logic agents must have been operative. The list of possi- 
ble candidates includes macrophages, platelets, clotting 
factors, kinins, and other inflammatory mediators [ 171. 
We were not able to examine the lung tissue of our 
patients precisely at the onset of the adult respiratory 
distress syndrome. However, we believe that information 
available for Patient 1 makes it unlikely that neutrophils 
were present in significant numbers early in his course. In 
particular, the patient had severe chemotherapy-induced 
neutropenia that began at least several days prior to the 
development of respiratory distress. At the time of death, 
not only were his lungs devoid of detectable neutrophils, 
but his bone marrow, the source of neutrophils, was also 
depleted. 
The occurrence of the respiratory distress syndrome in 
our three neutroperric patients does not preclude the 
possibility that neutrophils were important in some, if not 
all, of the remaining 15 patients. There is reason to 
believe that many distinct pathogenic mechanisms can 
lead to the syndrome. For example, acute noncardiogenic 
pulmonary edema would be expected to occur trom in- 
sults directed at capillary endothelium, basement mem- 
branes, alveolar epithelium, or alveolar surfactant 
[ 18,191. There is no a priori reasdn to suspect that there 
has to be a single damaging agent, e.g. the neutrophil. In 
fact, among the various animal models of acute respira- 
tory distress, some require the presence of neutrophils, 
and others do not [2,20]. 
In summary, neutropenia did not totally protect the 
lungs of bacteremic patients from the development of the 
adult respiratory distress syndrome. In three neutropenic 
patients with the syndrome, other etiologic agents must 
have been responsible. The adult respiratory distress 
syndrome is likely to be a multifactorial syndrome, possi- 
bly with both neutrophrl-dependent and neutrophil-inde- 
pendent pathogenic mechanisms. In the appropriate clini- 
cal setting, the diagnosis of the adult respiratory distress 
syndrome should not be excluded solely because the 
patient is neutropenic. 
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